Enlivex Therapeutics Stock Forecast

Sell candidate since Jun 04, 2026 Loss -21.19%

The Enlivex Therapeutics Ltd. stock price gained 0.209% on the last trading day (Monday, 22nd Jun 2026), rising from $0.622 to $0.623. During the last trading day the stock fluctuated 11.34% from a day low at $0.593 to a day high of $0.660. The price has fallen in 6 of the last 10 days and is down by -12.25% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 743 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $664.00 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -31.84% during the next 3 months and, with a 90% probability hold a price between $0.394 and $0.532 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

ENLV Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, June 17, 2026, and so far it has risen 0.81%. Further rise is indicated until a new top pivot has been found. Enlivex Therapeutics Ltd. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Enlivex Therapeutics Ltd. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.649 and $0.738. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Enlivex Therapeutics Ltd. stock

Enlivex Therapeutics Ltd. finds support from accumulated volume at $0.622 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0672 between high and low, or 11.34%. For the last week, the stock has had daily average volatility of 9.17%.

Enlivex Therapeutics Ltd. is oversold on RSI14 (16). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ENLV) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Enlivex Therapeutics Ltd. to open at $0.625, and during the day (based on 14 day Average True Range), to move between $0.592 and $0.654, which gives a possible trading interval of +/-$0.0615 (+/-10.38%) up or down from last closing price. If Enlivex Therapeutics Ltd. takes out the full calculated possible swing range there will be an estimated 10.38% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.622 (0.21%) than the resistance at $0.684 (9.79%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Enlivex Therapeutics Ltd. stock A Buy?

Enlivex Therapeutics Ltd. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -3.556 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $0.625 ( 0.364%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk